nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—ANPEP—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.0347	0.041	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR1—multiple sclerosis	0.0301	0.0356	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—VDR—multiple sclerosis	0.0205	0.0242	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CXCR3—multiple sclerosis	0.02	0.0236	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR2—multiple sclerosis	0.0194	0.023	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—BCHE—multiple sclerosis	0.0185	0.0219	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.0183	0.0216	CbGpPWpGaD
Icatibant—BDKRB2—nervous system—multiple sclerosis	0.0171	0.161	CbGeAlD
Icatibant—BDKRB2—central nervous system—multiple sclerosis	0.0165	0.155	CbGeAlD
Icatibant—BDKRB2—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.0162	0.0192	CbGpPWpGaD
Icatibant—BDKRB2—cerebellum—multiple sclerosis	0.0161	0.152	CbGeAlD
Icatibant—BDKRB2—G alpha (q) signalling events—GPR65—multiple sclerosis	0.0157	0.0186	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—IRF5—multiple sclerosis	0.0148	0.0174	CbGpPWpGaD
Icatibant—ANPEP—medulla oblongata—multiple sclerosis	0.0142	0.134	CbGeAlD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.0142	0.0168	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.0142	0.0168	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.014	0.0166	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.0138	0.0163	CbGpPWpGaD
Icatibant—BDKRB2—brain—multiple sclerosis	0.0131	0.123	CbGeAlD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.0129	0.0152	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR5—multiple sclerosis	0.0125	0.0148	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.0121	0.0143	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.012	0.0141	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.012	0.0141	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.0111	0.0131	CbGpPWpGaD
Icatibant—ANPEP—nervous system—multiple sclerosis	0.0107	0.101	CbGeAlD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.0104	0.0123	CbGpPWpGaD
Icatibant—ANPEP—central nervous system—multiple sclerosis	0.0103	0.0968	CbGeAlD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.0101	0.0119	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—S1PR1—multiple sclerosis	0.00982	0.0116	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—POMC—multiple sclerosis	0.00957	0.0113	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00951	0.0112	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00951	0.0112	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00939	0.0111	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00914	0.0108	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—VDR—multiple sclerosis	0.00854	0.0101	CbGpPWpGaD
Icatibant—ANPEP—brain—multiple sclerosis	0.00816	0.0769	CbGeAlD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.00806	0.00952	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00792	0.00936	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GPR65—multiple sclerosis	0.00792	0.00936	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CD4—multiple sclerosis	0.00777	0.00918	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—SPP1—multiple sclerosis	0.00773	0.00913	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00771	0.00911	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00761	0.009	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00759	0.00897	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—FAS—multiple sclerosis	0.00745	0.0088	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00735	0.00869	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL13—multiple sclerosis	0.00724	0.00856	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR1—multiple sclerosis	0.00724	0.00856	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00715	0.00845	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00711	0.0084	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00678	0.00801	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.0066	0.0078	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—SLC30A7—multiple sclerosis	0.00655	0.00774	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00653	0.00772	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00652	0.00771	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.0064	0.00757	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.0063	0.00744	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00613	0.00724	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00589	0.00696	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00566	0.00668	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—MYC—multiple sclerosis	0.00559	0.0066	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00555	0.00656	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00551	0.00651	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PABPC1—multiple sclerosis	0.0053	0.00626	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL3—multiple sclerosis	0.00516	0.0061	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00509	0.00602	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00504	0.00596	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00497	0.00587	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR5—multiple sclerosis	0.00497	0.00587	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCR3—multiple sclerosis	0.0048	0.00567	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—RPL5—multiple sclerosis	0.00478	0.00565	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00472	0.00558	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR2—multiple sclerosis	0.00467	0.00551	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00461	0.00545	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.0046	0.00544	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.0045	0.00532	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00447	0.00529	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00438	0.00518	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CNR1—multiple sclerosis	0.00431	0.00509	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RGS1—multiple sclerosis	0.00429	0.00506	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR1—multiple sclerosis	0.00409	0.00484	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00409	0.00484	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GPR65—multiple sclerosis	0.00406	0.0048	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00395	0.00467	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LINGO1—multiple sclerosis	0.00393	0.00464	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—POMC—multiple sclerosis	0.00388	0.00459	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00388	0.00458	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR1—multiple sclerosis	0.00372	0.00439	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00372	0.00439	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.0037	0.00438	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—BCHE—multiple sclerosis	0.0035	0.00413	CbGpPWpGaD
Icatibant—Injection site reaction—Cladribine—multiple sclerosis	0.00348	0.0734	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TAGAP—multiple sclerosis	0.00341	0.00403	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL5—multiple sclerosis	0.00334	0.00394	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.00316	0.00373	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00309	0.00365	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00302	0.00357	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR5—multiple sclerosis	0.00301	0.00355	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—S1PR1—multiple sclerosis	0.00298	0.00352	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GPC5—multiple sclerosis	0.0029	0.00342	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00281	0.00332	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00271	0.0032	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL3—multiple sclerosis	0.00265	0.00313	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00264	0.00312	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00255	0.00301	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RGS1—multiple sclerosis	0.00253	0.00299	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00246	0.00291	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00243	0.00288	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GPR65—multiple sclerosis	0.0024	0.00284	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR2—multiple sclerosis	0.00239	0.00283	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00236	0.00278	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—POMC—multiple sclerosis	0.00235	0.00278	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—multiple sclerosis	0.0023	0.00272	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CNR1—multiple sclerosis	0.00221	0.00261	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR1—multiple sclerosis	0.0022	0.00259	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL13—multiple sclerosis	0.0022	0.00259	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00219	0.00259	CbGpPWpGaD
Icatibant—Nervous system disorder—Fingolimod—multiple sclerosis	0.00216	0.0456	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00199	0.00235	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00189	0.00223	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00181	0.00214	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—POMC—multiple sclerosis	0.00181	0.00214	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—multiple sclerosis	0.00177	0.00209	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL5—multiple sclerosis	0.00171	0.00202	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR5—multiple sclerosis	0.0017	0.00201	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00167	0.00198	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL3—multiple sclerosis	0.00156	0.00185	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR5—multiple sclerosis	0.00154	0.00182	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2RA—multiple sclerosis	0.00152	0.0018	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTGER4—multiple sclerosis	0.00151	0.00178	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PGR—multiple sclerosis	0.00148	0.00175	CbGpPWpGaD
Icatibant—Dizziness—Fingolimod—multiple sclerosis	0.00146	0.0307	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CXCR3—multiple sclerosis	0.00145	0.00172	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CD28—multiple sclerosis	0.00144	0.0017	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR2—multiple sclerosis	0.00141	0.00167	CbGpPWpGaD
Icatibant—Headache—Fingolimod—multiple sclerosis	0.00138	0.0291	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—POMC—multiple sclerosis	0.00133	0.00157	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CNR1—multiple sclerosis	0.00131	0.00154	CbGpPWpGaD
Icatibant—Nervous system disorder—Cladribine—multiple sclerosis	0.00123	0.0258	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—POMC—multiple sclerosis	0.00121	0.00143	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—multiple sclerosis	0.00118	0.00139	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL10—multiple sclerosis	0.00118	0.00139	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TYK2—multiple sclerosis	0.00107	0.00127	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CD86—multiple sclerosis	0.00103	0.00121	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL5—multiple sclerosis	0.00101	0.0012	CbGpPWpGaD
Icatibant—Body temperature increased—Cladribine—multiple sclerosis	0.000988	0.0208	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—IL2—multiple sclerosis	0.000982	0.00116	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SPP1—multiple sclerosis	0.000937	0.00111	CbGpPWpGaD
Icatibant—Hypersensitivity—Cladribine—multiple sclerosis	0.000921	0.0194	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCR5—multiple sclerosis	0.000912	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2RA—multiple sclerosis	0.000898	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2—multiple sclerosis	0.000892	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOE—multiple sclerosis	0.000829	0.00098	CbGpPWpGaD
Icatibant—Dizziness—Cladribine—multiple sclerosis	0.000826	0.0174	CcSEcCtD
Icatibant—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000821	0.0173	CcSEcCtD
Icatibant—Body temperature increased—Azathioprine—multiple sclerosis	0.000803	0.0169	CcSEcCtD
Icatibant—Rash—Cladribine—multiple sclerosis	0.000788	0.0166	CcSEcCtD
Icatibant—Dermatitis—Cladribine—multiple sclerosis	0.000787	0.0166	CcSEcCtD
Icatibant—Headache—Cladribine—multiple sclerosis	0.000783	0.0165	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CD80—multiple sclerosis	0.00075	0.000886	CbGpPWpGaD
Icatibant—Hypersensitivity—Azathioprine—multiple sclerosis	0.000749	0.0158	CcSEcCtD
Icatibant—Nausea—Cladribine—multiple sclerosis	0.000742	0.0156	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—POMC—multiple sclerosis	0.000712	0.000842	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL2—multiple sclerosis	0.000697	0.000824	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000682	0.000806	CbGpPWpGaD
Icatibant—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000674	0.0142	CcSEcCtD
Icatibant—Dizziness—Azathioprine—multiple sclerosis	0.000672	0.0142	CcSEcCtD
Icatibant—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000649	0.0137	CcSEcCtD
Icatibant—Rash—Azathioprine—multiple sclerosis	0.000641	0.0135	CcSEcCtD
Icatibant—Dermatitis—Azathioprine—multiple sclerosis	0.00064	0.0135	CcSEcCtD
Icatibant—Headache—Azathioprine—multiple sclerosis	0.000637	0.0134	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TYK2—multiple sclerosis	0.000633	0.000748	CbGpPWpGaD
Icatibant—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00062	0.0131	CcSEcCtD
Icatibant—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000618	0.013	CcSEcCtD
Icatibant—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000606	0.0128	CcSEcCtD
Icatibant—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000605	0.0128	CcSEcCtD
Icatibant—Nausea—Azathioprine—multiple sclerosis	0.000604	0.0127	CcSEcCtD
Icatibant—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000562	0.0118	CcSEcCtD
Icatibant—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000562	0.0118	CcSEcCtD
Icatibant—Nervous system disorder—Betamethasone—multiple sclerosis	0.000551	0.0116	CcSEcCtD
Icatibant—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000551	0.0116	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL2—multiple sclerosis	0.000527	0.000622	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—multiple sclerosis	0.000524	0.000619	CbGpPWpGaD
Icatibant—Rash—Mitoxantrone—multiple sclerosis	0.000518	0.0109	CcSEcCtD
Icatibant—Dermatitis—Mitoxantrone—multiple sclerosis	0.000517	0.0109	CcSEcCtD
Icatibant—Headache—Mitoxantrone—multiple sclerosis	0.000515	0.0108	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MMP9—multiple sclerosis	0.000499	0.000589	CbGpPWpGaD
Icatibant—Hypersensitivity—Prednisolone—multiple sclerosis	0.000496	0.0105	CcSEcCtD
Icatibant—Body temperature increased—Triamcinolone—multiple sclerosis	0.00049	0.0103	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisone—multiple sclerosis	0.00049	0.0103	CcSEcCtD
Icatibant—Nausea—Mitoxantrone—multiple sclerosis	0.000488	0.0103	CcSEcCtD
Icatibant—Nervous system disorder—Prednisone—multiple sclerosis	0.00048	0.0101	CcSEcCtD
Icatibant—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000457	0.00962	CcSEcCtD
Icatibant—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000456	0.0096	CcSEcCtD
Icatibant—Dizziness—Prednisolone—multiple sclerosis	0.000446	0.00939	CcSEcCtD
Icatibant—Body temperature increased—Betamethasone—multiple sclerosis	0.000444	0.00937	CcSEcCtD
Icatibant—Body temperature increased—Dexamethasone—multiple sclerosis	0.000444	0.00937	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—STAT3—multiple sclerosis	0.000443	0.000524	CbGpPWpGaD
Icatibant—Rash—Prednisolone—multiple sclerosis	0.000425	0.00895	CcSEcCtD
Icatibant—Dermatitis—Prednisolone—multiple sclerosis	0.000424	0.00894	CcSEcCtD
Icatibant—Headache—Prednisolone—multiple sclerosis	0.000422	0.0089	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MYC—multiple sclerosis	0.000412	0.000487	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—multiple sclerosis	0.000411	0.000485	CbGpPWpGaD
Icatibant—Dizziness—Triamcinolone—multiple sclerosis	0.00041	0.00863	CcSEcCtD
Icatibant—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000409	0.00862	CcSEcCtD
Icatibant—Dizziness—Methylprednisolone—multiple sclerosis	0.000409	0.00862	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MAPK1—multiple sclerosis	0.000403	0.000476	CbGpPWpGaD
Icatibant—Nervous system disorder—Methotrexate—multiple sclerosis	0.000401	0.00846	CcSEcCtD
Icatibant—Nausea—Prednisolone—multiple sclerosis	0.0004	0.00843	CcSEcCtD
Icatibant—Rash—Triamcinolone—multiple sclerosis	0.000391	0.00823	CcSEcCtD
Icatibant—Dermatitis—Triamcinolone—multiple sclerosis	0.00039	0.00823	CcSEcCtD
Icatibant—Rash—Methylprednisolone—multiple sclerosis	0.00039	0.00821	CcSEcCtD
Icatibant—Dermatitis—Methylprednisolone—multiple sclerosis	0.00039	0.00821	CcSEcCtD
Icatibant—Headache—Triamcinolone—multiple sclerosis	0.000388	0.00818	CcSEcCtD
Icatibant—Headache—Methylprednisolone—multiple sclerosis	0.000387	0.00816	CcSEcCtD
Icatibant—Body temperature increased—Prednisone—multiple sclerosis	0.000387	0.00816	CcSEcCtD
Icatibant—Dizziness—Dexamethasone—multiple sclerosis	0.000372	0.00783	CcSEcCtD
Icatibant—Dizziness—Betamethasone—multiple sclerosis	0.000372	0.00783	CcSEcCtD
Icatibant—Nausea—Triamcinolone—multiple sclerosis	0.000368	0.00776	CcSEcCtD
Icatibant—Nausea—Methylprednisolone—multiple sclerosis	0.000367	0.00774	CcSEcCtD
Icatibant—Hypersensitivity—Prednisone—multiple sclerosis	0.000361	0.0076	CcSEcCtD
Icatibant—Rash—Dexamethasone—multiple sclerosis	0.000355	0.00747	CcSEcCtD
Icatibant—Rash—Betamethasone—multiple sclerosis	0.000355	0.00747	CcSEcCtD
Icatibant—Dermatitis—Dexamethasone—multiple sclerosis	0.000354	0.00746	CcSEcCtD
Icatibant—Dermatitis—Betamethasone—multiple sclerosis	0.000354	0.00746	CcSEcCtD
Icatibant—Headache—Dexamethasone—multiple sclerosis	0.000352	0.00742	CcSEcCtD
Icatibant—Headache—Betamethasone—multiple sclerosis	0.000352	0.00742	CcSEcCtD
Icatibant—Nausea—Betamethasone—multiple sclerosis	0.000334	0.00704	CcSEcCtD
Icatibant—Nausea—Dexamethasone—multiple sclerosis	0.000334	0.00704	CcSEcCtD
Icatibant—Dizziness—Prednisone—multiple sclerosis	0.000324	0.00682	CcSEcCtD
Icatibant—Body temperature increased—Methotrexate—multiple sclerosis	0.000324	0.00682	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL6—multiple sclerosis	0.00031	0.000366	CbGpPWpGaD
Icatibant—Rash—Prednisone—multiple sclerosis	0.000309	0.00651	CcSEcCtD
Icatibant—Dermatitis—Prednisone—multiple sclerosis	0.000308	0.0065	CcSEcCtD
Icatibant—Headache—Prednisone—multiple sclerosis	0.000307	0.00646	CcSEcCtD
Icatibant—Hypersensitivity—Methotrexate—multiple sclerosis	0.000302	0.00635	CcSEcCtD
Icatibant—Nausea—Prednisone—multiple sclerosis	0.000291	0.00613	CcSEcCtD
Icatibant—Dizziness—Methotrexate—multiple sclerosis	0.000271	0.0057	CcSEcCtD
Icatibant—Rash—Methotrexate—multiple sclerosis	0.000258	0.00544	CcSEcCtD
Icatibant—Dermatitis—Methotrexate—multiple sclerosis	0.000258	0.00543	CcSEcCtD
Icatibant—Headache—Methotrexate—multiple sclerosis	0.000256	0.0054	CcSEcCtD
Icatibant—Nausea—Methotrexate—multiple sclerosis	0.000243	0.00512	CcSEcCtD
